San Jose, CA, United States of America

Ryan Chan

This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignee: Roche Molecular Systems, Inc.. Active years: 2022-2024.

USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2022-2024

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Ryan Chan: Innovator in Antimicrobial Susceptibility Testing

Introduction

Ryan Chan is a notable inventor based in San Jose, CA (US). He has made significant contributions to the field of microbiology, particularly in the area of antimicrobial susceptibility testing. With a total of 2 patents, his work focuses on improving the rapid identification of bacteria and fungi.

Latest Patents

Ryan Chan's latest patents include compositions and methods for rapid identification and phenotypic antimicrobial susceptibility testing of bacteria and fungi. The present invention relates to the use of polymerase chain reaction (PCR) as a reporter assay for rapid and simultaneous bacterial identification and phenotype testing for antimicrobial susceptibility (AST). This innovative approach utilizes a strategy that has demonstrated the ability for multiplexing and effectively handling polymicrobial samples for antimicrobial susceptibility testing.

Career Highlights

Ryan Chan is currently employed at Roche Molecular Systems, Inc., where he continues to advance his research and development efforts. His work has been instrumental in enhancing the methodologies used in microbial testing, contributing to better healthcare outcomes.

Collaborations

Some of his coworkers include Kyle C Cady and Brett Hanson, who collaborate with him on various projects within the company.

Conclusion

Ryan Chan's contributions to antimicrobial susceptibility testing through his innovative patents highlight his role as a key figure in the field. His work not only advances scientific knowledge but also has practical implications for healthcare.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…